HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib

被引：0

作者：

Eric Wehrenberg-Klee

Nicoleta Sinevici

Sarah Nesti

Taylor Kalomeris

Emily Austin

Benjamin Larimer

Umar Mahmood

机构：

[1] Massachusetts General Hospital,Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology

来源：

Molecular Imaging and Biology | 2021年 / 23卷

关键词：

HER3; HER2; Lapatinib; Imaging; PET; Breast cancer; Precision medicine;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：930 / 940

页数：10

共 50 条

[1] HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib
Wehrenberg-Klee, Eric
Sinevici, Nicoleta
Nesti, Sarah
Kalomeris, Taylor
Austin, Emily
Larimer, Benjamin
Mahmood, Umar
[J]. MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (06) : 930 - 940
[2] Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer
Yun, Chen
Gang, Li
Gu Rongmin
Xu, Wen
Ming Xuezhi
Chen Huanqiu
[J]. MOLECULAR CARCINOGENESIS, 2015, 54 (12) : 1700 - 1709
[3] Functional genomics of HER2 and HER3 mutations and response to neratinib
Hanrahan, Aphrothiti J.
Hyman, David M.
Sfakianos, John
Jones, Alexis
Ramirez, Ricardo
Johnsen, Hannah
Lyer, Gopakumar
Al-Ahmadie, Hikmat A.
Bajorin, Dean
Bochner, Bernard H.
Coleman, Jonathan A.
Rosenberg, Jonathan E.
Berger, Michael F.
Chandarlapaty, Sarat
Baselga, Jose
Solit, David B.
[J]. CANCER RESEARCH, 2015, 75
[4] Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
Hanker, Ariella B.
Brown, Benjamin P.
Meiler, Jens
Marin, Arnaldo
Jayanthan, Harikrishna S.
Ye, Dan
Lin, Chang-Ching
Akamatsu, Hiroaki
Lee, Kyung-Min
Chatterjee, Sumanta
Sudhan, Dhivya R.
Servetto, Alberto
Brewer, Monica Red
Koch, James P.
Sheehan, Jonathan H.
He, Jie
Lalani, Alshad S.
Arteaga, Carlos L.
[J]. CANCER CELL, 2021, 39 (08) : 1099 - +
[5] Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, breast cancer progression, and HER2 inhibitor sensitivity
Hanker, Ariella B.
Jayanthan, Harikrishna Sekar
Ye, Dan
Lin, Chang-Ching
Akamatsu, Hiroaki
Sheehan, Jonathan H.
Koch, James P.
Sudhan, Dhivya R.
Brewer, Monica Red
Servetto, Alberto
He, Jie
Miller, Vincent A.
Lalani, Alshad S.
Meiler, Jens
Arteaga, Carlos L.
[J]. CANCER RESEARCH, 2020, 80 (04)
[6] Resistance to β1 integrin inhibition in HER2 amplified cancers is mediated by HER3
Park, Catherine C.
Amin, Dhara
Zhang, Hui
Moasser, Mark
[J]. CANCER RESEARCH, 2014, 74 (19)
[7] HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways
Choi, Byung-Kwon
Cai, Xiumei
Yuan, Bin
Huang, Zhao
Fan, Xuejun
Deng, Hui
Zhang, Ningyan
An, Zhiqiang
[J]. PROTEIN & CELL, 2012, 3 (10) : 781 - 789
[8] Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical Role
Yuan, Qinghua
Furukawa, Takako
Tashiro, Takahiro
Okita, Kouki
Jin, Zhao-Hui
Aung, Winn
Sugyo, Aya
Nagatsu, Kotaro
Endo, Hiroko
Tsuji, Atsushi B.
Zhang, Ming-Rong
Masuko, Takashi
Inoue, Masahiro
Fujibayashi, Yasuhisa
Saga, Tsuneo
[J]. PLOS ONE, 2015, 10 (11):
[9] Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer
Kanthala, Shanthi
Banappagari, Sashikanth
Gokhale, Ameya
Liu, Yong-Yu
Xin, Gu
Zhao, Yunfeng
Jois, Seetharama
[J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (06) : 702 - 714
[10] HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways
ByungKwon Choi
Xiumei Cai
Bin Yuan
Zhao Huang
Xuejun Fan
Hui Deng
Ningyan Zhang
Zhiqiang An
[J]. Protein & Cell., 2012, 3 (10) - 789

← 1 2 3 4 5 →